Lisata Therapeutics, Inc. (LSTA)
1.935
+0.08
(+4.03%)
USD |
NASDAQ |
Sep 09, 12:39
Lisata Therapeutics PE Ratio
PE Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical PE Ratio Data
| Date | Value |
|---|---|
| June 29, 2018 | 2.053 |
| June 28, 2018 | 2.053 |
| June 27, 2018 | 2.129 |
| June 26, 2018 | 2.190 |
| June 25, 2018 | 2.021 |
| June 22, 2018 | 2.167 |
| June 21, 2018 | 2.269 |
| June 20, 2018 | 2.742 |
| June 19, 2018 | 2.098 |
| June 18, 2018 | 1.253 |
| June 15, 2018 | 1.292 |
| June 14, 2018 | 1.285 |
| June 13, 2018 | 1.292 |
| June 12, 2018 | 1.247 |
| June 11, 2018 | 1.244 |
| June 08, 2018 | 1.231 |
| June 07, 2018 | 1.206 |
| June 06, 2018 | 1.209 |
| June 05, 2018 | 1.225 |
| June 04, 2018 | 1.215 |
| June 01, 2018 | 1.266 |
| May 31, 2018 | 1.263 |
| May 30, 2018 | 1.276 |
| May 29, 2018 | 1.301 |
| May 25, 2018 | 1.285 |
| Date | Value |
|---|---|
| May 24, 2018 | 1.272 |
| May 23, 2018 | 1.282 |
| May 22, 2018 | 1.285 |
| May 21, 2018 | 1.320 |
| May 18, 2018 | 1.349 |
| May 17, 2018 | 1.336 |
| May 16, 2018 | 1.295 |
| May 15, 2018 | 1.272 |
| May 14, 2018 | 1.269 |
| May 11, 2018 | 1.295 |
| May 10, 2018 | 1.298 |
| May 09, 2018 | 1.288 |
| May 08, 2018 | 1.314 |
| May 07, 2018 | 1.301 |
| May 04, 2018 | 1.345 |
| May 03, 2018 | 1.326 |
| May 02, 2018 | 1.320 |
| May 01, 2018 | 1.333 |
| April 30, 2018 | 1.323 |
| April 27, 2018 | 1.342 |
| April 26, 2018 | 1.333 |
| April 25, 2018 | 1.415 |
| April 24, 2018 | 1.428 |
| April 23, 2018 | 1.463 |
| April 20, 2018 | 1.469 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 12.49 |
| Alnylam Pharmaceuticals, Inc. | 43.17 |
| Anika Therapeutics, Inc. | -- |
| Savara, Inc. | -- |
| Vericel Corp. | 83.97 |
PE Ratio Related Metrics
| PS Ratio | 172.62 |
| Price to Book Value | 2.140 |
| Price | 1.935 |
| Earnings Yield | -84.80% |
| Market Cap | 17.65M |